Ovarian Cancer: Symptoms, Causes, Diagnosis and Treatment Options
Ovarian Cancer: Symptoms, Causes, Diagnosis and Treatment Options
Introduction
Ovarian cancer is a group of cancers that develop in or around the ovaries. The ovaries are reproductive organs that produce eggs and hormones such as estrogen and progesterone.
Ovarian cancers are not all the same. They can develop from different types of cells, including epithelial cells, germ cells and stromal cells. Epithelial tumors account for most ovarian cancers, while germ-cell and stromal tumors are less common.
Ovarian cancer can be difficult to recognize in its early stages because its symptoms may be mild or resemble common digestive or urinary problems. Persistent bloating, pelvic or abdominal discomfort, feeling full quickly and urinary frequency are among the symptoms that can occur.
Diagnosis usually involves a combination of medical history, physical and pelvic examination, imaging, blood tests and tissue evaluation. Treatment depends on the cancer type, stage, tumor characteristics and the patient's overall health.
Modern treatment may include surgery, chemotherapy, targeted therapy and, in selected situations, immunotherapy or clinical trials.
What Is Ovarian Cancer?
Ovarian cancer occurs when abnormal cells in or associated with the ovary begin to grow uncontrollably.
The ovaries are located on either side of the uterus. They are responsible for producing eggs and are an important source of reproductive hormones.
There are three major categories of ovarian tumors:
1. Epithelial Tumors
These develop from cells covering the ovary or related tissues and represent the majority of ovarian cancers.
2. Germ Cell Tumors
These develop from the cells that produce eggs.
3. Stromal Tumors
These develop from structural or hormone-producing cells of the ovary.
Ovarian cancer is also closely related to cancers arising in the fallopian tubes and primary peritoneum. These cancers can share biological characteristics and may be treated using similar approaches.
What Causes Ovarian Cancer?
There is no single cause responsible for all ovarian cancers.
Cancer develops when genetic and cellular changes allow abnormal cells to grow and survive when they normally should not.
Several factors may increase the likelihood of developing epithelial ovarian cancer.
These include:
- Increasing age
- Family history of ovarian or breast cancer
- Inherited BRCA1 or BRCA2 mutations
- Lynch syndrome
- Endometriosis
- Certain reproductive factors
- Previous radiation exposure to the pelvis
Having a risk factor does not mean that a person will definitely develop ovarian cancer. Some people develop ovarian cancer without having an obvious risk factor.
Ovarian Cancer Risk Factors
Age
Risk generally increases with age, and ovarian cancer is much less common in younger women. Many cases occur after menopause.
Family History
A family history of ovarian or breast cancer can increase risk.
BRCA1 and BRCA2
Inherited changes in the BRCA1 and BRCA2 genes are associated with increased risk of ovarian and certain other cancers.
Lynch Syndrome
Lynch syndrome is an inherited condition associated with increased risk of several cancers, including some ovarian cancers.
Endometriosis
Endometriosis has been associated with an increased risk of certain ovarian cancer types.
Risk factors vary by ovarian cancer subtype, so individual assessment is important.
Symptoms of Ovarian Cancer
Ovarian cancer can cause symptoms that are easy to confuse with gastrointestinal or urinary conditions.
Common symptoms include:
- Persistent bloating
- Abdominal discomfort or pain
- Pelvic pain
- Feeling full quickly when eating
- Difficulty eating normally
- Increased urinary frequency
- Urinary urgency
- Abdominal swelling
- Constipation
- Back pain
- Fatigue
- Pain during sexual activity
- Changes in menstrual bleeding in some patients
These symptoms do not automatically indicate ovarian cancer. Many non-cancerous conditions can cause the same symptoms.
However, symptoms that are persistent, worsening or unusual for the individual should be medically evaluated.
Why Ovarian Cancer Can Be Difficult to Detect Early
One of the challenges with ovarian cancer is that early symptoms may be nonspecific.
Bloating, indigestion, abdominal discomfort or urinary changes can occur with many common conditions.
There is currently no screening test that has been shown to reliably detect ovarian cancer early in the general population. Routine pelvic examinations also cannot reliably detect every early ovarian tumor.
For this reason, awareness of persistent symptoms and appropriate medical evaluation are important.
How Is Ovarian Cancer Diagnosed?
Diagnosis generally requires multiple types of information.
Medical History
A healthcare professional may ask about:
- Current symptoms
- Duration of symptoms
- Menstrual history
- Previous medical conditions
- Family history of cancer
- Previous cancer treatment
Pelvic Examination
A pelvic examination can help identify abnormalities involving the reproductive organs or surrounding tissues.
Ultrasound
Pelvic ultrasound can help evaluate an ovarian mass and determine whether further testing is necessary.
CT or MRI
Imaging may help determine the location and extent of suspected disease.
Blood Tests
Blood tests can provide additional information.
CA-125 may be measured in some patients, but an elevated CA-125 does not by itself prove that ovarian cancer is present. Other medical conditions can also increase CA-125.
Tissue Diagnosis
Pathological examination of tissue is important for confirming cancer and determining its type.
The exact diagnostic pathway depends on the patient's symptoms and clinical findings.
Genetic Testing in Ovarian Cancer
Genetic testing can be an important part of modern ovarian cancer evaluation.
Some ovarian cancers are associated with inherited genetic changes, particularly BRCA1 and BRCA2.
Testing may help:
- Identify inherited cancer risk
- Inform treatment decisions
- Determine eligibility for certain targeted therapies
- Provide information relevant to family members
Tumor testing may also evaluate genetic or molecular changes within the cancer itself.
The appropriate tests depend on the cancer type and the individual clinical situation.
Ovarian Cancer Stages
Staging describes how far the cancer has spread.
Broadly, ovarian cancer may be categorized from earlier disease confined to the ovaries or nearby structures to more advanced disease involving distant areas.
Staging is important because it helps clinicians determine:
- Treatment approach
- Surgical strategy
- Need for systemic therapy
- Prognosis
- Follow-up planning
The final stage is determined using clinical evaluation, imaging, surgical findings and pathological information.
Ovarian Cancer Treatment Options
Treatment depends on:
- Cancer type
- Stage
- Tumor biology
- Genetic findings
- Overall health
- Previous treatment
- Whether the disease is newly diagnosed or recurrent
For epithelial ovarian cancer, major treatment approaches include surgery, chemotherapy and targeted therapy. Clinical trials may also provide access to emerging treatments.
Surgery for Ovarian Cancer
Surgery can have several purposes.
It may be used to:
- Remove the primary tumor
- Determine the extent of disease
- Obtain tissue for diagnosis
- Remove visible cancer from the abdomen and pelvis
- Help establish the cancer stage
For advanced ovarian cancer, surgeons may perform cytoreductive or debulking surgery, with the goal of removing as much visible cancer as possible.
The exact procedure depends on the disease and the patient's circumstances.
Chemotherapy
Chemotherapy uses anticancer medicines to destroy or control cancer cells.
For many epithelial ovarian cancers, platinum-based chemotherapy forms an important part of treatment.
Chemotherapy may be given:
- Before surgery
- After surgery
- For advanced disease
- For recurrent disease
The specific regimen depends on cancer type, stage, previous therapy and patient factors.
Targeted Therapy for Ovarian Cancer
Targeted therapy focuses on specific biological processes that cancer cells use to survive and grow.
This differs from conventional chemotherapy, which generally affects rapidly dividing cells.
Targeted therapies may include drugs that interfere with:
- Tumor blood-vessel formation
- DNA repair
- Specific molecular pathways
NCI identifies targeted therapy as an established treatment category for ovarian epithelial, fallopian tube and primary peritoneal cancers.
PARP Inhibitors and Ovarian Cancer
PARP inhibitors are an important class of targeted cancer therapies.
PARP proteins are involved in repairing certain types of DNA damage. Blocking PARP can make it more difficult for some cancer cells to repair DNA damage, potentially leading to cancer-cell death.
This approach can be particularly relevant in ovarian cancers with certain defects in DNA-repair pathways, including some cancers associated with BRCA mutations.
Examples of PARP inhibitors used in appropriate ovarian cancer settings have included:
- Olaparib
- Niraparib
- Rucaparib
Eligibility and approved uses vary according to disease characteristics, previous treatment and regulatory requirements.
Recurrent Ovarian Cancer
Ovarian cancer can return after initial treatment.
This is called recurrent ovarian cancer.
When recurrence occurs, doctors may reassess:
- Previous treatments
- Duration of response
- Current symptoms
- Disease location
- Molecular characteristics
- BRCA or other relevant testing
- General health
Treatment options may include additional chemotherapy, targeted therapy, PARP inhibitors in appropriate settings, surgery in selected patients or participation in clinical trials.
Platinum-Sensitive and Platinum-Resistant Disease
The response of recurrent ovarian cancer to platinum-based chemotherapy can influence subsequent treatment decisions.
Some cancers remain responsive to platinum-based treatment after recurrence, while others become resistant.
This distinction helps oncologists select subsequent therapies and combinations.
Treatment should therefore be individualized rather than based solely on the cancer's name.
Supportive Care During Ovarian Cancer Treatment
Cancer treatment involves more than controlling the tumor.
Supportive care may address:
- Pain
- Nausea and vomiting
- Fatigue
- Nutrition
- Anemia
- Infection risk
- Emotional wellbeing
- Treatment-related side effects
- Recovery after surgery
Good supportive care can help patients manage treatment and maintain quality of life.
When Should You Talk to a Doctor?
Persistent or unusual symptoms should not automatically be assumed to be ovarian cancer, but they should be evaluated when they do not resolve or represent a significant change from normal.
Important symptoms include:
- Persistent bloating
- Ongoing abdominal or pelvic pain
- Feeling full unusually quickly
- Persistent urinary urgency or frequency
- Increasing abdominal swelling
- Unexplained weight loss
- Persistent fatigue
- Unusual vaginal bleeding
The American Cancer Society recommends discussing persistent symptoms with a healthcare professional, particularly when they occur more frequently or are different from a person's normal pattern.
15 Frequently Asked Questions
1. What is ovarian cancer?
Ovarian cancer is a group of cancers arising from different cell types in or around the ovaries.
2. What are the most common symptoms of ovarian cancer?
Bloating, pelvic or abdominal pain, feeling full quickly and urinary urgency or frequency are among the common symptoms.
3. Can ovarian cancer cause bloating?
Yes. Persistent abdominal bloating or swelling can occur with ovarian cancer.
4. Is ovarian cancer difficult to detect early?
Yes. Early ovarian cancer may produce few or nonspecific symptoms, and there is no screening test that reliably detects ovarian cancer early in the general population.
5. What causes ovarian cancer?
There is no single known cause. Age, inherited genetic changes and family history are among factors associated with increased risk.
6. Are BRCA mutations related to ovarian cancer?
Yes. Inherited BRCA1 and BRCA2 mutations can substantially increase the risk of certain ovarian cancers.
7. How is ovarian cancer diagnosed?
Evaluation may include medical history, pelvic examination, imaging, blood tests and tissue examination.
8. Does a high CA-125 mean ovarian cancer?
No. CA-125 can be elevated for reasons other than ovarian cancer, so it cannot be used alone to establish a diagnosis.
9. What is the main treatment for ovarian cancer?
Treatment commonly involves surgery and systemic therapy such as chemotherapy, with targeted therapy used in appropriate situations.
10. What are PARP inhibitors?
PARP inhibitors are targeted therapies that interfere with DNA-repair processes and can be useful in selected ovarian cancers.
11. Can ovarian cancer come back?
Yes. Ovarian cancer can recur after initial treatment.
12. What is recurrent ovarian cancer?
It means ovarian cancer has returned after a period in which the disease was controlled or undetectable.
13. Can ovarian cancer be treated with targeted therapy?
Yes. Targeted therapies are used in selected ovarian cancer settings based on disease characteristics and treatment history.
14. Is ovarian cancer hereditary?
Some ovarian cancers are associated with inherited genetic mutations, but not all cases are hereditary.
15. Is ovarian cancer curable?
Some ovarian cancers, particularly certain early-stage cancers, can be treated successfully. Outcomes vary considerably according to cancer type, stage, biology and response to treatment.
Global Medicine Information & Support by RootAid Pharma
Global Medicine Information & Support by RootAid Pharma
RootAid Pharma provides educational information and support related to specialty medicines, oncology and hematology treatment.
Our resources can help patients, caregivers and healthcare professionals better understand:
- Oncology medicines
- Gynecologic cancers
- Ovarian cancer
- Targeted cancer therapies
- PARP inhibitor therapy
- Specialty medicines
- Prescription-related information
- International medicine information
Medicine availability, prescribing requirements and regulatory approvals can vary between countries.
Need help after reading this?
Talk to our support team for sourcing guidance, product availability, and global delivery assistance.